Development of a low-cost real-time reverse transcriptase-polymerase chain reaction technique for the detection and quantification of hepatitis C viral load

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 6, 2010, Pages 777-784

  Shahzamani, Kiana ^a   Merat, Shahin ^a   Rezvan, Houri ^b   Mirab Samiee, Siamak ^c   Khademi, Hooman ^a   Malekzadeh, Reza ^a   Sabahi, Farzaneh ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

^c Food Quality Control Laboratory   (Iran)

^d Science Research Campus of Islamic Azad University   (Iran)

Author keywords

Hepatitis C virus; Hybridization probe; Real time reverse transcriptase PCR; Viral load

Indexed keywords

VIRUS RNA;

ARTICLE; BLOOD SAMPLING; COST BENEFIT ANALYSIS; DILUTION; GENOTYPE; HEPATITIS C; HUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; VIRUS GENE; VIRUS LOAD;

GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 77953202720     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.134     Document Type: Article

References (34)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244: 359-362
2. Moradpour D, Blum HE. A primer on the molecular virology of hepatitis C. Liver Int 2004;24:519-525
3. Alter MJ. Epidemiology of hepatitis C. Hepatology 1997;26(3 Suppl 1):62S-5.
4. Benvegnu L, Pontisso P, Cavalletto D, Noventa F, Chemello L, Alberti A. Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis. Hepatology 1997;25:211-215
5. Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, et al. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology 1995;22(4 Pt 1):1050-1056
6. Lee SS, Abdo AA. Predicting antiviral treatment response in chronic hepatitis C: how accurate and how soon? J Antimicrob Chemoth 2003;51:487-491
7. Toyoda H, Kumada T, Nakano S, Takeda I, Sugiyama K, Osada T, et al. Quasispecies nature of hepatitis C virus and response to alpha interferon: significance as a predictor of direct response to interferon. J Hepatol 1997;26:6-13.
8. Berger A, Preiser W, Doerr HW. The role of viral load determination for the management of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection. J Clin Virol 2001;20:23-30.
9. Reddy KR, Shiffman ML, Morgan TR, Zeuzem S, Hadziyannis S, Hamzeh FM, et al. Impact of ribavirin dose reductions in hepatitis C virus genotype 1 patients completing peginterferon a-2a/ribavirin treatment. Clin Gastroenterol Hepatol 2007;5: 124-129
10. Alter HJ, Sanchez-Pescador R, Urdea MS, Wilber JC, Lagier RJ, Di Bisceglie AM, et al. Evaluation of branched DNA signal amplification for the detection of hepatitis C virus RNA. J Viral Hepat 1995;2:121-132
11. Young KK, Archer JJ, Yokosuka O, Omata M, Resnick RM. Detection of hepatitis C virus RNA by a combined reverse transcription PCR assay: comparison with nested amplification and antibody testing. J Clin Microbiol 1995;33:654-657
12. Kinai E, Hanabusa H, Kato S. Prediction of the efficacy of antiviral therapy for hepatitis C virus infection by an ultrasensitive RT-PCR assay. J Med Virol 2007;79:1113-1119
13. Levis J, Kenny-Walsh E, O'Sullivan K, Horgan M, Whelton M, Shanahan F, et al. Strategy for the maximization of clinically relevant information from hepatitis C virus, RT-PCR quantification. J Clin Virol 2001;20:163-171
14. Raeymaekers L. Quantitative PCR: theoretical considerations with practical implications. Anal Biochem 1993;214:582-585
15. Yang JH, Lai JP, Douglas SD, Metzger D, Zhu XH, Ho WZ. Real-time RT-PCR for quantitation of hepatitis C virus RNA. J Virol Methods 2002;102:119-128
16. Hawkins A, Davidson F, Simmonds P. Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay, and an in-house limiting dilution method. J Clin Microbiol 1997;35:187-192
17. Caliendo AM, Valsamakis A, Zhou Y, Yen-Lieberman B, Andersen J, Young S, et al. Multilaboratory comparison of hepatitis C virus viral load assays. J Clin Microbiol 2006;44: 1726-1732
18. Germer JJ, Heimgartner PJ, Ilstrup DM, Harmsen WS, Jenkins GD, Patel R. Comparative evaluation of the VERSANT HCV RNA 3.0, QUANTIPLEX HCV RNA 2.0, and COBAS AMPLICOR HCV MONITOR version 2.0 assays for quantification of hepatitis C virus RNA in serum. J Clin Microbiol 2002;40:495-500.
19. Schroter M, Zollner B, Schafer P, Laufs R, Feucht HH. Quantitative detection of hepatitis C virus RNA by light cycler PCR and comparison with two different PCR assays. J Clin Microbiol 2001;39:765-768
20. Halfon P, Bourliere M, Penaranda G, Khiri H, Ouzan D. Realtime PCR assays for hepatitis C virus (HCV) RNA quantitation are adequate for clinical management of patients with chronic HCV infection. J Clin Microbiol 2006;44:2507-2511
21. Ratge D, Scheiblhuber B, Landt O, Berg J, Knabbe C. Tworound rapid-cycle RT-PCR in single closed capillaries increases the sensitivity of HCV RNA detection and avoids amplicon carry-over. J Clin Virol 2002;24:161-172
22. Espy MJ, Uhl JR, Sloan LM, Buckwalter SP, Jones MF, Vetter EA, et al. Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev 2006;19: 165-256.
23. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996;6:986-994
24. Bankowski MJ, Anderson SM. Real-time nucleic acid amplification in clinical microbiology. Clin Microbiol Newsl 2004;26:9-15.
25. Saldanha J, Heath A, Lelie N, Pisani G, Nubling M, Yu M. Calibration of HCV working reagents for NAT assays against the HCV international standard. The Collaborative Study Group. Vox Sang 2000;78:217-224
26. Ahmadipour MH, Keivani H, Sabahi F, Alavian SM. Determination of HCV genotypes, in Iran by PCR-RFLP. Iranian J Publ Health 2006;35:54-61.
27. Davis GL, Lindsay K, Albrecht J, Bodenheimer HC Jr, Balart LA, Perrillo RP, et al. Clinical predictors of response to recombinant interferon-alpha treatment in patients with chronic non- A, non-B hepatitis (hepatitis C). The Hepatitis Interventional Therapy Group. J Viral Hepat 1994;1:55-63.
28. Cockerill FR 3rd. Application of rapid-cycle real-time polymerase chain reaction for diagnostic testing in the clinical microbiology laboratory. Arch Pathol Lab Med 2003;127: 1112-1120
29. Castelain S, Descamps V, Thibault V, Francois C, Bonte D, Morel V, et al. TaqMan amplification system with an internal positive control for HCV RNA quantitation. J Clin Virol 2004;31:227-234
30. Pawlotsky JM, Roudot-Thoraval F, Bastie A, Darthuy F, Remire J, Metreau JM, et al. Factors affecting treatment responses to interferon-alpha in chronic hepatitis C. J Infect Dis 1996;174: 1-7.
31. Daniel HD, Grant PR, Garson JA, Tedder RS, Chandy GM, Abraham P. Quantitation of hepatitis C virus using an in-house real-time reverse transcriptase polymerase chain reaction in plasma samples. Diagn Microbiol Infect Dis 2008;61:415-420
32. Caplin BD, Rasmussen RP, Bernard PS. LightCycler hybridization probes: the most direct way to monitor PCR amplification for quantification and mutation detection. Biomedica 1999;1:5-8.
33. Ratge D, Scheiblhuber B, Nitsche M, Knabbe C. High-speed detection of blood-borne hepatitis C virus RNA by single-tube real-time fluorescence reverse transcription-PCR with the LightCycler. Clin Chem 2000;46:1987-1989
34. Watzinger F, Ebner K, Lion T. Detection and monitoring of virus infections by real-time PCR. Mol Aspects Med 2006;27: 254-298